Build status - In Progress
Electrogram Guided Myocardial Advanced Phenotyping (EMAP) Study for patients recently diagnosed with cardiomyopathy
Recruiting
18 years - 100 years
All
Phase
3
30 participants needed
1 Location
Brief description of study
This study is enrolling newly diagnosed heart failure (within 6 months from diagnosis) patients with no known cause for their heart disease. We are utilizing already used technology, voltage mapping capabilities used in electrophysiology procedures, to more directly target weaker areas of the left and right ventricles. our physicians would biopsy the places the mapping technology guides us, and our goal is to understand the potential benefit in yield of this technique.
Detailed description of study
patients will undergo a clinically indicated biopsy, and during this procedure we would biopsy the patient's heart tissue the standard way as well as the voltage mapping pathway. study subjects would get a clinical read from some of the tissue samples, and some will be banked for later analysis. We will follow patients clinically at three months for outcomes.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: heart failure,new diagnosis,non-ischemic,idiopathic,unknown cause,heart disease,biopsy,diagnosis,heart,cardiology
-
Age: 18 years - 100 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 826102
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or